- Home
- BRDG vs SEPN Comparison
BRDG vs SEPN Comparison
Compare BRDG & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRDG
- SEPN
- Stock Information
- Founded
- BRDG 2009
- SEPN 2022
- Country
- BRDG United States
- SEPN United States
- Employees
- BRDG N/A
- SEPN N/A
- Industry
- BRDG Investment Managers
- SEPN
- Sector
- BRDG Finance
- SEPN
- Exchange
- BRDG Nasdaq
- SEPN NYSE
- Market Cap
- BRDG 445.0M
- SEPN 522.7M
- IPO Year
- BRDG 2021
- SEPN 2024
- Fundamental
- Price
- BRDG $10.21
- SEPN $12.49
- Analyst Decision
- BRDG Hold
- SEPN Strong Buy
- Analyst Count
- BRDG 5
- SEPN 5
- Target Price
- BRDG $11.30
- SEPN $26.75
- AVG Volume (30 Days)
- BRDG 569.2K
- SEPN 249.0K
- Earning Date
- BRDG 08-05-2025
- SEPN 08-15-2025
- Dividend Yield
- BRDG 4.00%
- SEPN N/A
- EPS Growth
- BRDG N/A
- SEPN N/A
- EPS
- BRDG N/A
- SEPN N/A
- Revenue
- BRDG $453,729,000.00
- SEPN $977,000.00
- Revenue This Year
- BRDG N/A
- SEPN $3,429.67
- Revenue Next Year
- BRDG $36.21
- SEPN N/A
- P/E Ratio
- BRDG N/A
- SEPN N/A
- Revenue Growth
- BRDG 39.05
- SEPN 108.76
- 52 Week Low
- BRDG $7.09
- SEPN $4.17
- 52 Week High
- BRDG $11.69
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- BRDG 52.69
- SEPN N/A
- Support Level
- BRDG $10.33
- SEPN N/A
- Resistance Level
- BRDG $10.72
- SEPN N/A
- Average True Range (ATR)
- BRDG 0.25
- SEPN 0.00
- MACD
- BRDG -0.04
- SEPN 0.00
- Stochastic Oscillator
- BRDG 16.67
- SEPN 0.00
About BRDG Bridge Investment Group Holdings Inc.
Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.